CTU: A Phase 1b/2, Open-Label Umbrella Study to Evaluate Safety and Efficacy of Elacestrant in Various Combinations in Patients with Metastatic Breast Cancer (ELEVATE)

  • Sabanathan, Dhanusha (Primary Chief Investigator)
  • Chapman, Nicola (Clinical Trial Unit Staff)
  • TAIDI, Gina (Clinical Trial Unit Staff)
  • Chester, Catherine (Clinical Trial Unit Staff)
  • Contacos, Christine (Clinical Trial Unit Staff)

Project: Research

Project Details

Short titleSTML-ELA-0222
AcronymELEVATE
StatusActive
Effective start/end date9/08/23 → 22/11/28